Supply of asfotase alfa
Titre original de l'avis
Poland – Various medicinal products – DOSTAWA ASFOTAZY ALFA
Score d'opportunité
Pourquoi ce score ?
Opportunité
40 / 100
Complexité
20 / 100
Facteurs de risque
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
- Pays
- Pologne
- CPV
- 33690000 - Various medicinal products
- Date limite
- Aug 18, 2026
Aperçu
Moderate opportunityFaits clés
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of asfotase alfa injection solution (40 mg/ml) in three pack sizes: 0.45 ml (160 packs), 0.7 ml (30 packs), 1.0 ml (60 packs)
- Delivery to University Children's Clinical Hospital in Białystok, Poland
Afficher le résumé complet
Open tender for the supply of asfotase alfa (asfotazy alfa) to a children's hospital in Białystok, Poland. Single lot, 24-month contract. Award based solely on lowest price. No estimated value published, but a high bid bond (252,456 PLN) is required. The buyer is a public hospital. EU funding status is inconsistent between structured data (EU-funded) and notice (no EU funds). Eligibility includes pharmaceutical licenses. Only Polish language is accepted.
Risques
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Bid bond (wadium) of 252,456 PLN required before deadline
Administrative
- Submission via e-ProPublico platform only
- Offer must be signed with qualified electronic signature
Critères d'attribution
Lot 1
Acheteur
Localisation
Białystok, POL
Site web
Profil acheteur
Identifiant
542-25-34-063
Activité
Health
Lots (1)
LOT-0001
Supply of asfotase alfa
Delivery of asfotase alfa injection solution in three pack sizes: 40 mg/ml 0.45 ml (160 packs), 0.7 ml (30 packs), and 1.0 ml (60 packs) over 24 months to the University Children's Clinical Hospital in Białystok.
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Liczba punktów = ( Cmin/Cof ) * 100 * waga gdzie: - Cmin - najniższa cena spośród wszystkich ofert - Cof - cena podana w ofercie
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Dostawa asfotazy alfa
Description TED originale
1 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,45 ml x 12 fiol. OP 160 2 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,7 ml x 12 fiol. OP 30 3 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 1,0 ml x 12 fiol. OP 60
Détails de la procédure
- Date de publication
- 06 Jul 2026
- Langues
- Polish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 466950-2026
Documents (1)
Appels d'offres similaires
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Score d'opportunité
Pourquoi ce score ?
Opportunité
40 / 100
Complexité
20 / 100
Facteurs de risque
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications